Prostate News and Research

RSS

AI model can help doctors determine the extent of cancer within the prostate

A new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors determine the extent of cancer within the prostate.

27 Jun 2023

New kidney cancer model highlights molecular targets and genomic events that drive metastasis

Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.

26 Jun 2023

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.

26 Jun 2023

Adopting a 30th birthday genetic profile test could save lives and NHS costs

A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal genetic testing at the age of 30.

24 Jun 2023

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Study describes the use of engineered commensal bacteria to increase antitumor immunity.

23 Jun 2023

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

The University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health today announced a partnership to create Ochsner MD Anderson Cancer Center in southeastern Louisiana.

22 Jun 2023

Hypertension drug shown to prevent post-traumatic headaches

A study led by VA Puget Sound Health Care System researchers has shown that prazosin, a drug used to treat high blood pressure, can prevent posttraumatic headaches.

21 Jun 2023

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer."

21 Jun 2023

Researchers develop a prediction tool for blood cancer therapies

Since its introduction in 2015, a prediction tool developed by the European Society of Medical Oncology has been providing support worldwide in the assessment of the clinical benefits of new cancer therapies.

20 Jun 2023

‘Break the Silence’ campaign urges British fathers to discuss men's health issues with their sons

Men are often reluctant to talk about health matters, and that’s certainly true according to new research by GenesisCare, which reveals that nearly half (49%) of fathers admit they steer clear of talking about men’s health issues with their sons - because they don’t want to scare them (19%).

19 Jun 2023

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention.

16 Jun 2023

No improvement in freedom from progression rates for patients: Study

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.

16 Jun 2023

Rising alcohol consumption in China linked to increased risk of 61 diseases

The associations between alcohol consumption and the risk of diseases in Chinese adults.

12 Jun 2023

Study provides a possible treatment option for prostate cancer resistant to hormone therapy

Prostate cancer is the most-commonly diagnosed malignancy and the second leading cause of cancer death among men in the United States.

12 Jun 2023

Pandemic restrictions associated with a significant drop in cancer diagnoses

Pandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well as melanoma, according to a new Alberta study published in CMAJ (Canadian Medical Association Journal)

12 Jun 2023

Weak spot discovery could pave way for more effective cancer therapies

Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375'000 patients will die from it each year.

8 Jun 2023

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Researchers performed an observational study to determine the prevalence of germline genetic testing among all patients aged 20 years or older diagnosed with cancer between January 1, 2013, and March 31, 2019, in two United States, California and Georgia.

8 Jun 2023

Prostate News and Research

AI model can help doctors determine the extent of cancer within the prostate

New kidney cancer model highlights molecular targets and genomic events that drive metastasis

Personalized dosing improves outcomes for men with metastatic castration-resistant prostate cancer

Adopting a 30th birthday genetic profile test could save lives and NHS costs

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

Hypertension drug shown to prevent post-traumatic headaches

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

Researchers develop a prediction tool for blood cancer therapies

‘Break the Silence’ campaign urges British fathers to discuss men's health issues with their sons

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

No improvement in freedom from progression rates for patients: Study

Rising alcohol consumption in China linked to increased risk of 61 diseases

Study provides a possible treatment option for prostate cancer resistant to hormone therapy

Pandemic restrictions associated with a significant drop in cancer diagnoses

Weak spot discovery could pave way for more effective cancer therapies

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

INTEGRA Biosciences’ pipettes help to combat prostate cancer

American Indian and Alaska Native men less likely to be screened for prostate cancer, study shows

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News